IGF1R and rhabdomyosarcoma: A recent study on rhabdomyosarcoma has discovered that the overexpression and constant activation of PDGFRα, along with its amplification, serve as a mechanism of acquired resistance to a drug that aims the insulin-like growth factor I receptor (IGF-IR) [102].